Related Experiment Video
Updated: Aug 18, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
[Ferritin and other acute phase proteins in various forms of coronary heart disease]
Insights
High serum ferritin, fibrinogen, and C-reactive protein (CRP) indicate unstable angina (IA) in coronary heart disease (CHD) patients. Ferritin may reflect atherosclerotic plaque destabilization, especially in IA.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Clinical Diagnostics
Background:
- Coronary heart disease (CHD) encompasses various clinical presentations, including stable angina, painless myocardial ischemia (PMI), and unstable angina (IA).
- Biomarkers such as ferritin, fibrinogen, and C-reactive protein (CRP) are investigated for their role in inflammation and cardiovascular risk.
- Understanding the clinical significance of these markers in different CHD forms is crucial for patient management.
Purpose of the Study:
- To determine the clinical importance of elevated serum ferritin, fibrinogen, and CRP levels in patients with different forms of coronary heart disease (CHD).
- To assess the relationship between these biomarkers and the clinical presentation of CHD, particularly unstable angina (IA).
Main Methods:
- Sixty patients with diagnosed CHD (stable angina, PMI, or IA) identified via stress echocardiography were studied.
- A control group of 20 individuals with cardiovascular risk factors but no CHD was included.
- Routine clinical examinations and biochemical blood tests, including serum levels of ferritin, fibrinogen, CRP, iron, and total iron-binding capacity (TIBC), were performed.
Main Results:
- Serum levels of CRP, fibrinogen, and ferritin were significantly highest in patients with unstable angina (IA) compared to the control group.
- No significant differences in serum iron or TIBC were observed between groups.
- Significant correlations were found between ferritin and CRP in all CHD groups, and between ferritin and fibrinogen in IA patients, suggesting ferritin's role as an acute-phase reactant in CHD destabilization.
Conclusions:
- Elevated serum ferritin, in conjunction with fibrinogen and CRP, should be considered an indicator of acute phase response in patients with coronary heart disease (CHD).
- Particularly in patients with unstable angina (IA), serum ferritin may signify atherosclerotic plaque destabilization.
- These findings highlight the potential of ferritin as a biomarker for monitoring disease activity in CHD.
Abstract:
The purpose of the study was to determine clinical importance of high serum levels of ferritin, fibrinogen and C-reactive protein (CRP) in patients with various forms of coronary heart disease (CHD) such as stable angina, painless myocardial ischemia (PMI) and instable angina (IA). The subjects of the study were 60 patients with CHD, whose clinical variant (stable angina, PMI or IA) had been determined by stress echocardiography. The control group consisted of 20 patients, not suffering from CHD, but having cardiovascular risk factors (arterial hypertension, dyslipoproteinemia, male gender, obesity, elderly age). All patients underwent routine clinical examination and biochemical blood tests. Serum levels of CRP, fibrinogen and ferritin were highest in the patients with IA and significantly differed from those in the control group. The difference in serum iron levels and total iron-binding capacity in serum (TIBC) between the groups were insignificant. Correlations between serum level of iron, TIBC and ferritin level were found neither in CHD patients (r = 0.1) nor in the control group (r = 0.15). No correlation between serum level of ferritin and CRP level was observed in the control group, but in all CHD groups this correlation was significant. The strongest correlation between these values was observed in the patients with IA. Besides, correlations between serum levels of ferritin and CRP (r = 0.46, p < 0.02) and between ferritin and fibrinogen levels (r = 0.39, p < 0.05) were found in the patients with IA. In patients with CHD, especially those who have IA, serum ferritin should be considered among acute phase proteins, reflecting destabilization of atherosclerotic plaque.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis I: Introduction
